Express News | MannKind Corp: Expects to Ship Product for Cipla Ltd. by End of 2025

BreakingsDec 11 19:05

CDSCO Approves Afrezza (Insulin Human) Inhalation Powder in India

GlobeNewswireDec 11 19:00

MannKind Corporation's (NASDAQ:MNKD) Institutional Investors Lost 3.9% Last Week but Have Benefitted From Longer-term Gains

Simply Wall StNov 28 21:44

Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7

MT NewswiresNov 15 01:56 · Ratings

Oppenheimer Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 12 21:33 · Ratings

IntegriChain Revenue Optimization Experts to Speak at Informa's Pharma/BioTech GTN Summit

PR NewswireNov 11 22:14